Letters Optimising prostate biopsy

Author’s reply to Stainsby

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e1030 (Published 14 February 2012) Cite this as: BMJ 2012;344:e1030
  1. Bob Djavan, professor of urology1
  1. 1Department of Urology, New York University School of Medicine, New York University, New York, NY 10016, USA
  1. bob.djavan{at}nyumc.org

Evaluation and analysis of complications of prostate needle biopsy are certainly crucial when discussing benefits and harms of biopsy in times of increasing numbers of biopsies and biopsy cores. Stainsby’s suggestions may seem attractive but do not reflect our current understanding and are not supported by the current literature.1

All studies quoted were performed before or in the early days …

Sign in

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe